Clinical trials · Riverside–San Bernardino, CA
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 clinical trials in Riverside–San Bernardino
We’re tracking 5 recruiting stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 studies with a site in or near Riverside–San Bernardino — including Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Riverside–San Bernardino
- NCT06980038RecruitingPhase 2
Testing two immunotherapy drugs before surgery for advanced head and neck cancer
This trial tests whether adding a second immunotherapy drug (CDX-1140) to the standard immunotherapy cemiplimab before surgery is better than cemiplimab alone for people with stage III-IV head and neck cancer that can be removed with surgery.
Orange, CaliforniaAges 18 years+ - NCT02734537RecruitingPhase 2
Radiation with or without cisplatin after head and neck surgery
This trial studies whether adding cisplatin (a chemotherapy medicine) to radiation therapy helps people with stage III–IVA squamous cell cancer of the head and neck after they’ve had surgery. It’s meant to lower the risk of the cancer coming back.
Orange, CaliforniaAges 18 years+ - NCT06532279RecruitingPhase 2
Testing BMX-001 with chemoradiation for head and neck cancer
This trial tests whether adding BMX-001 (a drug that may protect healthy tissues) to standard chemoradiation can reduce side effects and improve outcomes for people with head and neck cancer. It's a randomized study, so you would have a 50/50 chance of getting BMX-001 or a placebo.
Buena Park, CaliforniaAges 18 years+ - NCT07441681RecruitingPhase 3
Comparing radiation plus targeted therapy vs standard chemo for head and neck cancer
This trial compares two treatments for advanced head and neck cancer in patients who cannot take the drug cisplatin. One group gets radiation plus a targeted drug called cetuximab, the other gets radiation plus standard chemotherapy. The goal is to see which approach works better and is safer for people who are not candidates for cisplatin.
Los Angeles, CaliforniaAges 18 years+ - NCT07195734RecruitingPhase 2
Adding chemo or immunotherapy before surgery for advanced head and neck cancer
This trial tests whether giving chemotherapy or chemotherapy plus immunotherapy before surgery can improve outcomes for people with advanced head and neck cancer that has come back or not gone away after prior treatment.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trial opens near Riverside–San Bernardino, CA
We’ll email you when one opens near Riverside–San Bernardino, CA — at most once a week, no account needed, unsubscribe anytime.
Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 trials in other cities
Where these studies are running near Riverside–San Bernardino
Institutions with a site for the recruiting stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 studies listed above.
- USC / Norris Comprehensive Cancer Center · 3 studies
- Los Angeles General Medical Center · 2 studies
- UC Irvine Health · 2 studies
- University of California, Irvine Medical Center / UC Irvine Health · 2 studies
- Cedars-Sinai Medical Center
- Desert Regional Medical Center
- Keck Medicine of USC Buena Park
- USC Norris Comprehensive Cancer Center
What taking part in a stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 studies in California.
Common questions
- Are there stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 clinical trials near Riverside–San Bernardino?
- Yes. We're currently tracking 5 recruiting stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 studies with a site near Riverside–San Bernardino, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 study near Riverside–San Bernardino?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Riverside–San Bernardino to take part?
- Not necessarily. These studies have a site near Riverside–San Bernardino, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New stage iva oropharyngeal (p16-negative) carcinoma ajcc v8 studies open near Riverside–San Bernardino regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.